Beruflich Dokumente
Kultur Dokumente
WHEN EDWARDS AND STEPTOE STARTED CLINICAL IVF, HUMAN OOCYTES WERE SUCCESSFULLY FERTILIZED AND GROWN IN VITRO, HOWEVER, NO PREGNANCY RESULTED FOR THE FIRST SEVEN YEARS.
IT WAS THEN REALIZED THAT THE FAILURE OF EMBRYOS TO IMPLANT WAS DUE TO LUTEAL PHASE DISRUPTION
THE ASPIRATION OF GRANULOSA CELLS THAT SURROUND THE OOCYTE, AND THE USE OF GnRh a DURING A R T CAN INTERFERE WITH THE PRODUCTION OF PROGESTERONE DURING THE LUTEAL PHASE WHICH IS NECESSARY FOR IMPLANTATION
( GARCIA ET AL. FERTIL&STERIL 1981 )
LUTEAL
PHASE SUPPORT IN IVF AGONIST AND ANTAGONIST PROTOCOLS IS CONSIDERED ESSENTIAL FOR OPTIMAL SUCCESS
HABAYTER,MUASHER FERTIL.STERIL 2008 APRIL (4) 749-58
ALL SYSTEMIC REVIEWS AND METAANALYSIS HAVE CONFIRMED THE IMPORTANCE OF LPS IN ART
PRITTS ET AL. HUMAN REPRODUCTION 2002 DAYA ET AL. COCHRANE DATA BASE SYS REV 2004
Which support ?
Which support ?
PROGESTERON
)GnRh-a )
( HCG (
PROGESTERONE
PROGESTERONE ADMINISTRATION SIGNIFICANTLY IMPROVED FERTILITY OUTCOMES IN ART COMPARED TO NO TREATMENT.
HCG
HCG IS EQUIVALENT TO PROGESTERONE BUT HAS HIGHER OHSS
Luteal E 2 supplementation
Higher preg and implantation rates are observed in icsi cycles in women supplemented with E2 in the luteal phase
Luteal E 2 supplementation
L P ESTROGEN
Oral 2-6 mg/day Gelbaya et al, Fertil,steril 2008 Transdermal Serna et al fertil,steril 2008 And vaginal Fertil,steril 2008 89 (3) 554-61 Did not change ICSI outcome
GnRh-a
Implantation rates are less in antagonist cycles
(Al-Inany et al. cochrane data base 2006)
GnRh-a
GnRH receptors in endometrium are blocked after GnRH antagonist ( Meserman et et al. Human Reproduction 2003( Luteal phase administration of GnRH-a has a beneficial effect on implantation in LP
(tesarike et al. Human Reproduction 2006)
GnRH-a
IT IS USED AT TIME OF HCG
(Schachter et al Fertil&Steril 2008)
ROUTE
IN 1992 SMITZ ET AL. REPORTED THAT THE IM ROUTE IS THE MOST COMMONLY USED
ROUTE
ORAL PROGESTERONE WAS FOUND TO BE ASSOCIATED WITH SIGNIFICANTLY LOWER IMPLANTATION AND PREGNANCY RATES, HIGH MISCARRIAGE RATES,OR BOTH COMPARED WITH IM OR VAGINAL ROUTE
FRIEDLER ET AL. HUMAN REPRODUCTION 1999
ROUTE
Compared to vaginal gel ,IM injections have significantly higher pregnancy And delivery rates.
ROUTE
LOCAL AND SYSTEMIC ALLERGIC REACTIONS TO THE OIL IN IM INJECTIONS MAY RESULT.
DOSE
THE DOSE OF IM PROGESTERONE IS 50100mg/day DAILY INJECTION WITH 25 AND 100 mg PROGESTERONE WAS COMPARED, AND NO SIGNIFICANT DIFFERENCE IN CLINICAL PREGNANCY OR DELIVERY RATE WAS FOUND
CHECK ET AL J IN VITRO FERT EMBRYO TRASF 1991
DOSE
ORAL OR VAGINAL PROGESTERONE IS GIVEN IN THE FORM OF MICRONIZED PREPARATION IN A DOSE OF 400-600 mg/day
DURATION
THE DURATION OF LPS IS VARIABLE IN DIFFERENT STUDIES, FROM SUPPLEMENTATION FOR 2 TO 3 WKS ONLY AND THROUGH 10 TO 12 WKS OF GESTATION
PRITTS AND ATWOOD HUMAN REPROD 2002
Duration of LPS
In a prospective R study comparing LPS for ICSI patients up to the first US compared with an additional three weeks,done in 21 IVF centers.
Duration of LPS
The study found no statistical difference reguarding miscarriage rate up to 20 wks. They concluded that their randomized trial did not support extending LPS beyond the day of first us demonstrating pulsations
Aboulghar et al. Human Reproduction 2008
CONCLUSIONS
SUMMARY
ADDITION OF ESTROGEN TO PROGESTERONE MAY IMPROVE IMPLANTATION RATE MIDLUTEAL E2 DEFINES PATIENTS IN NEED FOR E2 SUPPLEMENTATION
IM, AND VAGINAL ROUTES ARE THE MOSTLY PREFERRED THE INITIATION, THE DOSE AND THE DURATION OF LPS ARE STILL GREATLY VARIABLE, NEED FURTHER STUDIES.